NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
Herrlinger U, Küker W, Uhl M; Blaicher HP, Karnath HO, Kanz L, Bamberg M, Weller M; Neuro-Oncology Working Group of the German Cancer Society
Ann Neurol 2005;57: 843 – 847